Biotech · Private company · Newton, MA, US
ImmunoChem Therapeutics, LLC
Track this companyFree. Adds ImmunoChem Therapeutics, LLC to your Dealase workspace and tells you when its record changes.
Clinical trials10 recruiting or active
Pipeline programs1From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline1
- MW151Phase 1 · Cognitive Dysfunction, Cognitive DisorderClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials1
- MW151 and Whole-brain Radiotherapy in Patients With Intracranial MetastasesPHASE1 · COMPLETED · started Jul 1, 2022ClinicalTrials.gov NCT05417282 · fetched Nov 12, 2026
NIH awards3
- Development of a novel anti-neuroinflammatory experimental therapeutic for epilepsy and Alzheimer's riskFiscal year 2025 · $50KNIH RePORTER 3R44AG071062-03S1 · fetched Nov 12, 2026
- Development of a novel anti-neuroinflammatory experimental therapeutic for epilepsy and Alzheimer's riskFiscal year 2025 · $1.2MNIH RePORTER 5R44AG071062-03 · fetched Nov 12, 2026
- Development of a novel anti-neuroinflammatory experimental therapeutic for epilepsy and Alzheimer's riskFiscal year 2024 · $1.2MNIH RePORTER 4R44AG071062-02 · fetched Nov 12, 2026